Changes in Mean Arterial and Blood Pressure in Using Nicardipine in Hypertensive Crisis Patients at the Hajj General Hospital Surabaya from August to December 2021
Article Sidebar
-
Nicardipine, Hypertension, emergency, mean arterial pressure
Abstract
Hypertension crisis is one of the most common disease problems; it will cause complications and death. Therapeutic management guidelines that the calcium channel blocker group, one of which is nicardipine, can increase the achievement of goals in mean arterial pressure (MAP) in preventing the progression of organ damage. This study aimed to evaluate the use of nicardipine therapy on the MAP and blood pressure (BP) in patients with hypertension crisis. The research design was cross-sectional with statistical analysis—retrospective data collection at Hajj General Hospital Surabaya for August to December 2021. The number of samples in this study matched the inclusion criteria; 20 patients were obtained, 16 with a diagnosis of hypertension emergency, and four with hypertension urgency who received single or combined intravenous nicardipine therapy <0.005 with an average BP decrease of pre 20.375±31.492/103.50±10.400 mmHg and post 121.34±14.364/81.80±11.186 so that intravenous nicardipine therapy was significant in reducing systolic and diastolic BP. In the profile of the MAP value statistically using the paired T-test, it was found that the P-value was 0.000 < 0.005 with a decrease in the MAP pre-value of 135.028±13.8857 mmHg and post 93.650±8.9499 mmHg, showing a reduction in MAP as expected. In conclusion, using nicardipine intravenously at a 5 mg/hour dose has shown an optimal decrease in BP and MAP in hypertensive emergency and urgency patients.
Full text article
References
2. Pierin AMG, Flórido CF, Dos Santos J. Hypertensive crisis: clinical characteristics of patients with hypertensive urgency, emergency and pseudocrisis at a public emergency department. Einstein. 2019;17(4):aAO4685. doi:10.31744/einstein_journal/2019ao4685
3. Vidt DG. Hypertensive crises: emergencies and urgencies. J Clin Hypertens. 2004;6(9):520-5. doi:10.1111/j.1524-6175.2004.03607.x
4. Fandinata SS, Ernawati I. The Effects of Self Reminder Card to the Successful Treatment of Blood Pressure of Hypertension Patients in Community Health Centers in Surabaya. STRADA J Ilmiah Kesehatan. 2020;9(2):831–9. doi:10.30994/sjik.v9i2.395
5. Masenga SK, Sijumbila G. Hypertensive Urgency in Low- and Middle-Income Countries. Am J Hypertens. 2020;33(12):1084-6. doi:10.1093/ajh/hpaa132
6. Balahura AM, Moroi SI, Scafa-Udrişte A, Weiss E, Japie C, Bartoş D, et al. The Management of Hypertensive Emergencies-Is There a "Magical" Prescription for All? J Clin Med. 2022;11(11):3138. doi:10.3390/jcm11113138
7. Kulkarni S, Glover M, Kapil V, Abrams SML, Partridge S, McCormack T, et al. Management of hypertensive crisis: British and Irish Hypertension Society Position document. J Hum Hypertens. 2022. doi:10.1038/s41371-022-00776-9
8. Ghazi L, Li F, Simonov M, Yamamoto Y, Nugent JT, Greenberg JH, et al. Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage. J Hypertens. 2023;41(2):288-94. doi:10.1097/hjh.0000000000003328
9. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension. Blood Press. 2018;27(6):314-40. doi:10.1080/08037051.2018.1527177
10. Handler J. Hypertensive urgency. J Clin Hypertens. 2006;8(1):61-4. doi:10.1111/j.1524-6175.2005.05145.x
11. Guerrero-García C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context. 2018;7:212531. doi:10.7573/dic.212531
12. Brozovich FV, Nicholson CJ, Degen CV, Gao YZ, Aggarwal M, Morgan KG. Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders. Pharmacol Rev. 2016;68(2):476-532. doi:10.1124/pr.115.010652
13. Koroki T, Abe T, Ochiai H. Nicardipine versus nitroglycerin for hypertensive acute heart failure syndrome: a single-center observational study. J Rural Med. 2022;17(1):33-9. doi:10.2185/jrm.2021-045
14. Mikawa K, Nishina K, Maekawa N, Obara H. Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. Br J Anaesth. 1996;76(2):221–6. doi:10.1093/bja/76.2.221
15. Lambert CR, Hill JA, Nichols WW, Feldman RL, Pepine CJ. Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol. 1985;55(6):652-6. doi:10.1016/0002-9149(85)90130-4
16. Malesker MA, Hilleman DE. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically Ill patients. J Crit Care. 2012;27(5):528.e7-14. doi:10.1016/j.jcrc.2011.12.005
17. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223-37. doi:10.1038/s41581-019-0244-2
18. Farhud DD. Impact of Lifestyle on Health. Iran J Public Health. 2015;44(11):1442-4.
19. Benetos A, Petrovic M, Strandberg T. Hypertension Management in Older and Frail Older Patients. Circ Res. 2019;124(7):1045-60. doi:10.1161/circresaha.118.313236
20. Kuriakose D, Xiao Z. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020;21(20):7609. doi:10.3390/ijms21207609
21. Donkor ES. Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke Res Treat. 2018;2018:3238165. doi:10.1155/2018/3238165
22. Talle MA, Ngarande E, Doubell AF, Herbst PG. Cardiac Complications of Hypertensive Emergency: Classification, Diagnosis and Management Challenges. J Cardiovasc Dev Dis. 2022;9(8):276. doi:10.3390/jcdd9080276
23. Raina R, Mahajan Z, Sharma A, Chakraborty R, Mahajan S, Sethi SK, et al. Hypertensive Crisis in Pediatric Patients: An Overview. Front Pediatr. 2020;8:588911. doi:10.3389/fped.2020.588911
24. Wang AL, Iadecola C, Wang G. New generations of dihydropyridines for treatment of hypertension. J Geriatr Cardiol. 2017;14(1):67-72. doi:10.11909/j.issn.1671-5411.2017.01.006
25. Sarafidis PA, Georgianos PI, Malindretos P, Liakopoulos V. Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents. Expert Opin Investig Drugs. 2012;21(8):1089–106. doi:10.1517/13543784.2012.693477
26. Rosendorff C, Writing Committee. Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement. Am J Med. 2016;129(4):372-8. doi:10.1016/j.amjmed.2015.10.045
27. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131(6):1949-62. doi:10.1378/chest.06-2490
28. Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and Control of Hypertension: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72(11):1278-93. doi:10.1016/j.jacc.2018.07.008
29. Aronow WS. Treatment of hypertensive emergencies. Ann Transl Med. 2017;5(Suppl 1):S5. doi:10.21037/atm.2017.03.34
30. Almas A, Ghouse A, Iftikhar AR, Khursheed M. Hypertensive Crisis, Burden, Management, and Outcome at a Tertiary Care Center in Karachi. Int J Chronic Dis. 2014;2014:413071. doi:10.1155/2014/413071
31. Alshami A, Romero C, Avila A, Varon J. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018;15(7):504-12. doi:10.11909/j.issn.1671-5411.2018.07.007
32. Palupi PD, Rahmawati F, Robosuseno. Perbandingan Respon Klinik Nikardipin Dengan Diltiazem Pada Hipertensi Emergensi. J Manajemen Pelayanan Farmasi J Manag Pharm Pract. 2015;5(3):179-84. doi:10.22146/jmpf.206
Authors
Copyright (c) 2023 Selly Septi Fandinata, Rizky Darmawan, Ninik Mas Ulfa, Deddy Aryanda Putra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish with this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal, right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles of work (eg, post-institutional repository) or publish it in a book, with acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process, as can lead to productive exchanges, as well as earlier and greater citation of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.
Article Details
